Kidney Transplant Recipients With Hepatitis C Virus Experienced 100% SVR12 Rate When Treated With Sofosbuvir-Ledipasvir

Hepatology - United States
doi 10.1002/hep.29339
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy